Date:8/21/2009

per of the world's first and best-selling MRI-compatible monitoring system. Our staff has a combined 60+ years developing MRI-safe products. The MRidium(TM) Infusion System has full benefit of the experience and attention to details so important to the development of quality equipment which can be safely used in the MRI setting.

http://www.iradimed.com

MRidium(TM) is a Trademark of IRadimed Corporation

Masimo(R) and Masimo SET(R) are registered trademarks of Masimo Corporation.

    Contact:

    Todd Weber
    Vice President Sales and Marketing
    IRadimed Corporation
    407-677-8022 Ext. 112
    tweber@iradimed.com

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.

'/>"/>

SOURCE IRadimed Corporation Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related medicine news :

1. Nihon LocalSoft Designs New Japanese Software for IRadimed Corporations Award-Winning MRidium MRI Infusion System
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)